1. Home
  2. IMNN vs MTR Comparison

IMNN vs MTR Comparison

Compare IMNN & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • MTR
  • Stock Information
  • Founded
  • IMNN 1982
  • MTR 1979
  • Country
  • IMNN United States
  • MTR United States
  • Employees
  • IMNN N/A
  • MTR N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • MTR Oil & Gas Production
  • Sector
  • IMNN Health Care
  • MTR Energy
  • Exchange
  • IMNN Nasdaq
  • MTR Nasdaq
  • Market Cap
  • IMNN 12.9M
  • MTR 10.6M
  • IPO Year
  • IMNN 1985
  • MTR N/A
  • Fundamental
  • Price
  • IMNN $5.33
  • MTR N/A
  • Analyst Decision
  • IMNN Buy
  • MTR
  • Analyst Count
  • IMNN 2
  • MTR 0
  • Target Price
  • IMNN $182.61
  • MTR N/A
  • AVG Volume (30 Days)
  • IMNN 153.1K
  • MTR 2.8K
  • Earning Date
  • IMNN 11-06-2025
  • MTR 01-01-0001
  • Dividend Yield
  • IMNN N/A
  • MTR 3.24%
  • EPS Growth
  • IMNN N/A
  • MTR N/A
  • EPS
  • IMNN N/A
  • MTR 0.21
  • Revenue
  • IMNN N/A
  • MTR $580,337.00
  • Revenue This Year
  • IMNN N/A
  • MTR N/A
  • Revenue Next Year
  • IMNN N/A
  • MTR N/A
  • P/E Ratio
  • IMNN N/A
  • MTR $24.12
  • Revenue Growth
  • IMNN N/A
  • MTR N/A
  • 52 Week Low
  • IMNN $4.70
  • MTR $4.70
  • 52 Week High
  • IMNN $41.22
  • MTR $10.42
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 47.96
  • MTR 32.96
  • Support Level
  • IMNN $5.04
  • MTR $5.12
  • Resistance Level
  • IMNN $5.55
  • MTR $5.34
  • Average True Range (ATR)
  • IMNN 0.29
  • MTR 0.14
  • MACD
  • IMNN 0.04
  • MTR -0.05
  • Stochastic Oscillator
  • IMNN 70.94
  • MTR 0.00

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About MTR Mesa Royalty Trust

Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.

Share on Social Networks: